EB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net | Clinical Infectious Diseases |  | 2018 | 327 | 172 | ||
| Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others | The Journal of Law, Medicine & Ethics |  | 2018 | 409 | 0 | ||
| Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires | Orphanet journal of rare diseases | | 2015 | 566 | 1,590 | ||
| Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries | Orphanet journal of rare diseases | | 2015 | 553 | 432 | ||
| Development of new antibiotics: taking off finally? | Schweizerische medizinische Wochenschrift | | 2015 | 489 | 518 | ||
| Challenges and solutions for clinical development of new antibacterial agents: Results of a survey among pharmaceutical industry professionals | Antimicrobial agents and chemotherapy | | 2015 | 552 | 1 | ||
| Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies | Future microbiology |  | 2014 | 695 | 0 |
